MedPath
NMPA Approval

Trifluridine and Tipiracil Hydrochloride Tablets

国药准字HJ20190048

August 6, 2024

H20190048

Drug Information

曲氟尿苷替匹嘧啶片

片剂

曲氟尿苷15mg,盐酸替匹嘧啶7.065mg(相当于替匹嘧啶6.14mg)

化学药品

August 6, 2024

April 24, 2029

Company Information

Applicant Company

1-27, Kandanishiki-cho, Chiyoda-ku, Tokyo, 101-8444, Japan

Manufacturing Company

1-1, Iuchi, Takabo, Kitajima-cho, Itano-gun, Tokushima, 771-0206, Japan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

曲氟尿苷替匹嘧啶片 - NMPA 批准文号 | MedPath